<DOC>
	<DOCNO>NCT01927146</DOCNO>
	<brief_summary>By literature review , clear trend towards potential role human epidermal growth factor receptor 2 ( HER2 ) negative prognostic factor gastric cancer show , half analysis use multivariate statistic . Besides , For study current review look Lauren classification relation HER2 , high level overexpression amplification find intestinal phenotype compare diffuse mixed type . As lauren classification report independent prognostic factor result favor outcome gastric cancer ( GC ) , may probably histologic bias exists compare overall survival ( OS ) HER2 statuses without control confound . Similarly , patient different disease setting ( early stage advanced stage ; resectable metastatic ) affect outcomes either . In study , investigator retrospectively analyze HER2 status lauren classification 800 gastric patient receive gastrectomy Cancer Center Sun Yat-Sen University January 1996 December 2006 formalin-fixed paraffin- embed tumor tissue sample . To avoid potential influence histologic classification disease setting , investigator assess difference OS HER2 positive HER2 negative group resectable Lauren classification GCs , evaluate prognostic value HER2 status accord tumor-node-metastasis ( TNM ) stage .</brief_summary>
	<brief_title>Lauren Classifications HER2 Status Gastric Cancer Patients</brief_title>
	<detailed_description>It 's single site , retrospective study review medical record tissue test . Eight hundred gastric adenocarcinoma patient integrity medical record regular survival follow receive gastrectomy Cancer Center Sun Yat-Sen University January 1996 December 2006 retrospectively study . Formalin-fixed paraffin-embedded tumor tissue sample retrospectively test human epidermal growth factor receptor 2 ( HER2 ) Lauren classification status . Her2 positive define : immunohistochemistry ( IHC ) 2+ fluorescence situ hybridization ( FISH ) + ; IHC 3+ . 1 . After HER2 status lauren classification identifying , population use overall survival ( OS ) comparison Cohort 1 ( HER2 positive ) Cohort 2 ( negative group ) carry . According Tumor-node-metastasis ( TNM ) classification , OS compare cohort different stage . 2 . Correlate histopathological characteristic HER2 status lauren classification perform total 800 patient . Meanwhile , independent prognostic factor identification confirm clinicopathological feature , include gender ( male female ) , age diagnosis , tumor size ( ≤5cm &gt; 5cm ) , location primary tumor ( proximal distal ) , histology subtypes ( well + moderate differentiate adenocarcinoma poorly + signet ring cell differentiate adenocarcinoma ) , lauren classification ( diffuse type intestinal type mixed type ) , anemia ( yes ) , angiolymphatic invasion ( yes ) , TNM stag system ( American Joint Committee Cancer ( AJCC ) 7th edition ) , HER2 status ( negative positive ) .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Patients ' admission date : 19962006 . 2 . Histologically confirm gastric adenocarcinoma patient underwent gastrectomy . 3 . Adequate paraffin embed tumor tissue sample pathologic human epidermal growth factor receptor 2 ( HER2 ) status analysis . 4 . Integrity medical record regular survival follow , overall survival ( OS ) could source . 1 . Age＜18 year old . 2 . Other malignancy within last 5 year , except carcinoma situ cervix , basal cell carcinoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Lauren classification</keyword>
	<keyword>HER2 status</keyword>
	<keyword>Resectable gastric cancer</keyword>
</DOC>